Invariant chain can bind MHC class II at a site other than the peptide binding groove

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4777-4784

  Wilson, Nancy A ^a   Wolf, Paula ^c   Ploegh, Hidde ^c   Ignatowicz, Leszek ^d   Kappler, John ^a   Marrack, Philippa ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; SULFUR 35;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SPLEEN CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BINDING SITES; CHOLIC ACIDS; DETERGENTS; ENDOCYTOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYBRIDOMAS; MICE; OVALBUMIN; PEPTIDES; PROTEIN CONFORMATION; T-LYMPHOCYTES;

EID: 0032213264     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Cresswell, P. 1994. Assembly, transport and function of MHC class II molecule. Annu. Rev. Immunol. 12:259.
2. Sekaly, R. P., C. Tonnelle, M. Strubin, B. Mach, and E. O. Long. 1986. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J. Exp. Med. 164:1490.
3. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompalibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
4. Lamb, C. A., and P. Cresswell. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148: 3478.
5. Roche, P. A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA 88:3150.
6. Koch, N., W. Lauer, J. Habicht, and B. Dobberstein. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii): an alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6:1677.
7. O'Sullivan, D. M., D. Noonan, and V. Quaranta. 1987. Four in variant chain forms derived from a single gene by alternative splicing and alternative initiation of transcription/translation. J. Exp. Med. 166:444.
8. Strubin, M., C. Berte, and B. Mach. 1986. Alternative splicing and alternative initiation of translation explain the four forms of the Ii antigen-associated in variant chain. EMBO J. 5:3483.
9. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600.
10. Zhong, G., F. Castellino, P. Romagnoli, and R. N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:2061.
11. Stumptner, P., and P. Benaroch. 1997. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16:5807.
12. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
13. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
14. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. I. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
15. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
16. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
17. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.
18. Vogt, A. B., L. J. Stern, C. Amshoff, B. Dobberstein, G. J. Hammerling, and H. Kropshofer. 1995. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155:4757.
19. Karp, D. R., R. N. Jenkins, and E. O. Long. 1992. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc. Natl. Acad. Sci. USA 89:9657.
20. Romagnoli, P., and R. N. Germain. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med 180:1107.
21. Park, S. J., S. Sadeghnasseri, and D. C. Wiley. 1995. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl. Acad. Sci. USA 92:11289.
22. Bijlmakers, M.-J. J. E., P. Benaroch, and H. L. Ploegh. 1994. Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J. 13:2699.
23. Bijlmakers, M.-J. E., P. Benaroch, and H. L. Ploegh. 1994. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180:623.
24. Ignatowicz, L., J. Kappler, and P. Marrack. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84:521.
25. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
26. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
27. Kappler, J., B. Skidmore, J. White and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin 2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
28. Kessler, S. W. 1975. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol. 115:1617.
29. Murphy, D. B., D. Lo, S. Rath, R. L. Brinster, R. A. Flavell, A. Slanetz, and C. A. J. Janeway. 1989. A novel MHC class II epitope expressed in thymic medulla but not on cortex. Nature 338:765.
30. Janeway, C. A., Jr., P. J. Conrad, E. A. Lerner, J. Babich, P. Wettstein, and D. B. Murphy. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cell bound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662.
31. Koch, N., S. Koch, and G. J. Hammerling. 1982. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature 299:644.
32. Noelle, R. J., W. A. Kuziel, C. R. Maliszewski, E. McAdams, E. S. Vitetta, and P. W. Tucker. 1986. Regulation of the expression of multiple class II genes in murine B cells by B cell stimulatory factor-1 (BSF-1) J. Immunol. 137:1718.
33. Metlay, J. P., M. D. Witmer-Pack, R. Agger, M. T. Crowley, D. Lawless, and R. M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171: 1753.
34. Elliott, T., A. Willis, V. Cerundollo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
35. Ignatowicz, L., G. Winslow, J. Bill, J. Kappler, and P. Marrack. 1995. Cell surface expression of class II MHC proteins bound by a single peptide. J. Immunol. 154:3852.
36. Tampe, R., B. R. Clark, and H. M. McConnell. 1991. Energy transfer between two peptides bound to one MHC class II molecule. Science 254:87.
37. de Kroon, A. I. P. M., H., M. McConnell. 1994. Kinetics and specificity of peptide-MHC class II complex displacement reactions. J. Immunol. 152:609.
38. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
39. Liang, M. N., C. Beeson, K. Mason, and H. M. McConnell. 1995. Kinetics of the reaction between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol. 7:1397.
40. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181:677.
41. Benaroch, P., M. Yilla, G. Raposo, K. Ito, K. Miwa, H. J. Geuze, and H. L. Ploegh. 1995. How MHC class II molecules reach the endocytic pathway. EMBO J. 14:37.
42. Hershberg, R. M., P. E. Framson, D. H. Cho, L. Y. Lee, S. Kovats, J. Beitz, and J. S. Blum. 1997. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J. Clin. Invest. 100:204.
43. Castellino, F., G. Zhong, and R. N. Germain. 1997. Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum. Immunol. 54:159.
44. Zhong, G., P. Romagnoli, and R. N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429.